VAREX IMAGING CORP DL-,01 Logo
US92214X1063
A2DKK2
VREX

VAREX IMAGING CORP DL-,01

Loading quotes...

Forecast

The analysts' average price target is €13.11 (-21.02%). The median is €13.11 (-21.02%).

Buy
  2
Hold
  5
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Varex Imaging expects earnings jump in quarterly report on 10 August 2026

    Varex Imaging will release results for the most recent quarter on 10 August 2026. Analysts on average expect an EPS of 0.21 USD (prior year: -2.15 USD) and revenue of 215.5 million USD (prior year: 203.0 million USD). For the current fiscal year, analysts forecast on average an EPS of 0.907 USD and revenue of 871.0 million USD (prior year: 844.6 million USD). » More on finanzen.net


  • Varex Imaging beats Q2 EPS expectations, gross margin falls and stock drops after hours

    Varex Imaging reported Q2 fiscal 2026 EPS of $0.21 on revenue of $216 million, both slightly above forecasts. Non-GAAP gross margin fell to 34% (down 240 basis points), mainly due to higher raw material costs, while operating expenses increased. The stock fell 2.79% to $11.99 in after-hours trading, despite planned investments in AI-enabled imaging and photon-counting technology. The company sees EPS of $0.23 for Q3 and $0.30 for Q4. » More on de.investing.com


  • Varex Imaging sees steady demand, tariff relief and India ramp to lift margins

    Varex Management says recent geopolitical events have not materially affected demand, with healthcare stable and security inquiries flat to positive. The company expects modest gross-margin improvement of roughly 30–50 basis points as higher-tariff inventory clears and is pursuing supply-chain diversification and local manufacturing. Growth and profitability levers include an India manufacturing ramp targeting about $100 million of incremental radiographic revenue over ~two years, expansion in photon-counting CT and cargo-inspection businesses, and a debt refinancing that should save about $7–8 million annually (~$0.15–$0.16 EPS). » More on finance.yahoo.com


  • Varex Imaging outlines growth plans with photon-counting and expansion in India

    At the Sidoti Small‑Cap Conference, Varex Imaging presented its strategy: growth will be driven by photon‑counting technology, increased production in India and strong demand for cargo inspection systems. The company passed on customs costs to customers, significantly reduced the coupon on its debt from 7.875% to about 6% and paid down debt, increasing financial flexibility. Production in India is up and running but not yet at full capacity; x‑ray tube manufacturing is expected to be completed by year‑end, with revenues anticipated from 2027. The first photon‑counting customer system is planned for early 2027 and is likely to materially boost free cash flow together with completed plants. Political uncertainty and volatile conditions remain key risks. » More on de.investing.com


  • Varex Imaging outlines growth and cost-cutting plan at Oppenheimer conference

    Varex Imaging presented a strategic overview and emphasized resilience to geopolitical tensions and tariff changes. The company expects a slight improvement in gross margin from reduced tariffs and anticipates around $100 million in incremental revenue from its India site by fiscal 2027. Varex is advancing photon-counting technology and aims to partner with at least three OEMs by 2028. A debt refinancing reduces interest costs and saves $7–8 million annually; direct operational impacts from the geopolitical situation are considered minimal. » More on de.investing.com

Financials

In the last quarter, VAREX IMAGING CORP DL-,01 had revenue of €183.96M and net profit of €13.72M
(EUR) July 2026
YoY
Revenue 183.96M 6.74%
Gross profit 67.03M 16.97%
Net profit 13.72M 118.14%
EBITDA 25.34M 141.99%

Fundamentals

Metric Value
Market capitalization
€705.96M
Number of shares
42.46M
52-week high/low
€16.84 - €8.22
Dividends No
Beta
1.03
P/E ratio
35.03
PEG ratio
0.21
P/B ratio
1.56
P/S ratio
0.90

Company profile

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

Name
VAREX IMAGING CORP DL-,01
CEO
Sunny S. Sanyal
Headquarters Salt Lake City, ut
USA
Website
Sector
Health Care
Industry
Health Care Technology
IPO
01/23/2017
Employees 2,500

Ticker symbols

Exchange Symbol
NASDAQ
VREX
Frankfurt
VI4.F
DĂĽsseldorf
VI4.DU
SIX
VI4.SW
MĂĽnchen
VI4.MU
🍪

Parqet  uses cookies. Learn more